Fluvoxamine-induced erectile dysfunction responding to sildenafil

Journal of Sex and Marital Therapy

Volumn 24, Issue 4, 1998, Pages 313-317

  Balon, Richard ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; FLUVOXAMINE; SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; DRUG ACTIVITY; DRUG DEPENDENCE; DRUG MECHANISM; HUMAN; IMPOTENCE; MALE; SOCIAL PHOBIA;

ADULT; ENZYME INHIBITORS; FLUVOXAMINE; HUMANS; MALE; PENILE ERECTION; PIPERAZINES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 0031771105     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239808403967     Document Type: Article

References (14)

1. Balon R, Yeragani VK, Pohl R, Ramesh C: Sexual dysfunction during antidepressant treatment. J Clin Psychiatry.54:209-212, 1993.
2. Segraves RT: Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59(Suppl 4): 48-54, 1998.
3. Harvey KV, Balon R: Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 7:189-201, 1995.
4. Segraves RT: Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monograph 10(2): 4-10, 1992.
5. Balon R: Selective serotonin reputake inhibitors and sexual dysfunction. Primary Psychiatry 4:28 +31-33; 1997.
6. Nafziger AN, Goss-Bley A, Bertino JS Jr, Kashuba ADM: Incidence of sexual dysfunction in normal volunteers on fluvoxamine dierapy. Presented at New Research, APA 150di Annual Meeting, San Diego, California, May 17-22, 1997 (NR Abstract 229).
7. Balon R: The effect of antidepressants on human sexuality: Diagnosis and management. Primary Psychiatry 2:46-51; 1995.
8. Guirguis WR: Oral treatment for erectile dysfunction: From herbal remedies to designer drugs. J Sex & Marital Ther 24:69-73, 1998.
9. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in die treatment of erectile dysfunction. N Engl J Med 335:1397-1404.
10. Wicker P: Effects of oral sildenafil on intercourse success in patients with erectile dysfunction of broad-spectrum etiology. Presented at New Research, APA 151st Annual Meeting, Toronto, Ontario, Canada, May 30-June 4, 1998 (NR Abstract 304).
11. Guirguis WR, Maytom MC, Orr M, Osterloh IH, Smidi MD: Sildenafil for erectile dysfunction: A one-year study. Presented at the 151st American Psychiatric Association Annual Meeting, Toronto, Ontario, Canada, May 30-June 4, 1999 (Paper Session Abstract 63).
12. Segraves RT: Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 46:275-284, 1989.
13. Sheline Y, Bardgett ME, Csernansky JG: Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. J Clin Psychopharm 17:11-14, 1997.
14. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C: Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8:47-52, 1996.